Kodiak Sciences Inc (KOD) Stock Price, Quote, News & History

KODNASDAQ
$41.31
1.233.07%
At close: Jul 10, 5:00 PM EST
$41.87
0.561.36%
After Hours: 5:51 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-146.94M
Investing Cash Flow (TTM)
-1.18M
Financing Cash Flow (TTM)
178.80M
Free Cash Flow (TTM)
-148.12M
Capital Expenditure (TTM)
-1.18M
Net Change in Cash (TTM)
30.68M

Analyst Trends and Forecast

1
Jan
1
Feb
2
Mar
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.47B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
22.37
Earnings Yield % (TTM)
-10.40%
Earnings Yield % (FWD)
-8.68%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.79

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$169.53M
Debt to Equity
0.50
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$39.62
Close
$41.31
Volume / Avg.
996.64K / 751.15K
Day Range
$37.05 - $42.18
52 Wk Range
3.87 - 47.84
Market Cap
$2.62B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
63
Short Interest
26.56%
Days to Cover
13.65

About

Sector
Health Care
Industry
Biotechnology
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Kodiak Sciences (KOD) stock?

A

You can purchase shares of Kodiak Sciences (NASDAQ:KOD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kodiak Sciences (KOD) competitors?

A

There are no as such competitors for Kodiak Sciences.

Q

What is the forecast, or price target, for Kodiak Sciences (KOD) stock?

A

Kodiak Sciences has a consensus price target of $32.20.

Q

What is the current price for Kodiak Sciences (KOD)?

A

The stock price for Kodiak Sciences (NASDAQ: KOD) is $41.87 last updated July 10, 2026 at 5:51 PM EDT.

Q

Does Kodiak Sciences (KOD) pay a dividend?

A

There are no upcoming dividends for Kodiak Sciences.

Q

When is Kodiak Sciences (NASDAQ:KOD) reporting earnings?

A

Kodiak Sciences does not have any upcoming earnings scheduled.

Q

Is Kodiak Sciences (KOD) going to split?

A

There is no upcoming split for Kodiak Sciences.

Q

What sector and industry does Kodiak Sciences (KOD) operate in?

A

Kodiak Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.